Janus Henderson Group plc 13D and 13G filings for Maze Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 12:49 pm Purchase | 2025-09-30 | 13G | Maze Therapeutics, Inc. MAZE | JANUS HENDERSON GROUP PLC JHG | 3,206,472 7.300% | 581,383 (+22.15%) | Filing |
| 2025-08-14 11:46 am Purchase | 2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE | JANUS HENDERSON GROUP PLC JHG | 2,625,089 6.000% | 126,978 (+5.08%) | Filing |
| 2025-05-14 11:48 am Purchase | 2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE | JANUS HENDERSON GROUP PLC JHG | 2,498,111 5.700% | 2,498,111 (New Position) | Filing |